249 related articles for article (PubMed ID: 10534151)
1. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.
Friedman SR; Chapman TF; Perlis TE; Rockwell R; Paone D; Sotheran JL; Des Jarlais DC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):83-91. PubMed ID: 10534151
[TBL] [Abstract][Full Text] [Related]
2. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.
Des Jarlais DC; Arasteh K; Hagan H; McKnight C; Perlman DC; Friedman SR
Am J Public Health; 2009 Oct; 99 Suppl 2(Suppl 2):S445-51. PubMed ID: 19797757
[TBL] [Abstract][Full Text] [Related]
3. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
[TBL] [Abstract][Full Text] [Related]
4. Overview of HIV among injection drug users in New York City: critical next steps to eliminate racial/ethnic disparities.
Amesty S; Rivera AV; Fuller CM
Subst Use Misuse; 2011; 46(2-3):285-94. PubMed ID: 21303248
[TBL] [Abstract][Full Text] [Related]
5. Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?
Des Jarlais D; Arasteh K; McKnight C; Feelemyer J; Hagan H; Cooper H; Campbell A; Tross S; Perlman D
PLoS One; 2015; 10(5):e0126180. PubMed ID: 25965957
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in sexual behaviors related to AIDS in a nineteen-city sample of street-recruited drug injectors. NADR Consortium.
Friedman SR; Young PA; Snyder FR; Shorty V; Jones A; Estrada AL
AIDS Educ Prev; 1993; 5(3):196-211. PubMed ID: 8217472
[TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.
Brooks AJ; Lokhnygina Y; Meade CS; Potter JS; Calsyn DA; Greenfield SF
Am J Addict; 2013; 22(2):136-47. PubMed ID: 23414499
[TBL] [Abstract][Full Text] [Related]
8. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users.
Kottiri BJ; Friedman SR; Neaigus A; Curtis R; Des Jarlais DC
J Acquir Immune Defic Syndr; 2002 May; 30(1):95-104. PubMed ID: 12048369
[TBL] [Abstract][Full Text] [Related]
9. Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.
Wejnert C; Hess KL; Hall HI; Van Handel M; Hayes D; Fulton P; An Q; Koenig LJ; Prejean J; Valleroy LA
MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(47):1336-1342. PubMed ID: 27906906
[TBL] [Abstract][Full Text] [Related]
10. Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.
Cooper HL; Brady JE; Friedman SR; Tempalski B; Gostnell K; Flom PL
J Urban Health; 2008 Nov; 85(6):826-56. PubMed ID: 18709555
[TBL] [Abstract][Full Text] [Related]
11. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study.
Koblin BA; McCusker J; Lewis BF; Sullivan JL
Am J Epidemiol; 1990 Nov; 132(5):837-46. PubMed ID: 2239898
[TBL] [Abstract][Full Text] [Related]
13. Syringe type and drug injector risk for HIV infection: a case study in Texas.
Zule WA; Desmond DP; Neff JA
Soc Sci Med; 2002 Oct; 55(7):1103-13. PubMed ID: 12365524
[TBL] [Abstract][Full Text] [Related]
14. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
15. HIV risk factors among injecting drug users in five US cities.
Battjes RJ; Pickens RW; Haverkos HW; Sloboda Z
AIDS; 1994 May; 8(5):681-7. PubMed ID: 8060548
[TBL] [Abstract][Full Text] [Related]
16. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
[TBL] [Abstract][Full Text] [Related]
17. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.
Des Jarlais C; Perlis T; Friedman SR; Chapman T; Kwok J; Rockwell R; Paone D; Milliken J; Monterroso E
Am J Public Health; 2000 Jul; 90(7):1112-6. PubMed ID: 10897190
[TBL] [Abstract][Full Text] [Related]
18. Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.
Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C; Marshall DM
J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S325-S332. PubMed ID: 28604434
[TBL] [Abstract][Full Text] [Related]
19. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
Lee HH; Weiss SH; Brown LS; Mildvan D; Shorty V; Saravolatz L; Chu A; Ginzburg HM; Markowitz N; Des Jarlais DC
J Infect Dis; 1990 Aug; 162(2):347-52. PubMed ID: 2373871
[TBL] [Abstract][Full Text] [Related]
20. The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil.
Hacker MA; Friedman SR; Telles PR; Teixeira SL; Bongertz V; Morgado MG; Bastos FI
Subst Use Misuse; 2005; 40(1):99-123. PubMed ID: 15702651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
